N-(1-cyclopropylethyl)-5-(3,3-difluoropiperidin-1-yl)-7-methylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-5-ethyl-7-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-ethyl-5-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(2-cyclopropylpropan-2-yl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide
C91H113F2N25O7 — CID 163502094
Data last refreshed: (MolForge compound catalog, from PubChem)
IUPACN-(1-cyclopropylethyl)-5-(3,3-difluoropiperidin-1-yl)-7-methylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-5-ethyl-7-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-ethyl-5-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(2-cyclopropylpropan-2-yl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide
SMILESCCc1cc(-c2ccccn2)n2ncc(C(=O)NC(C)C3CC3)c2n1.CCc1cc(-c2ccccn2)nc2c(C(=O)NC(C)C3CC3)cnn12.Cc1cc(N2CCCC(F)(F)C2)nc2c(C(=O)NC(C)C3CC3)cnn12.Cc1cc(N2CCOCC2)nc2c(C(=O)NC(C)(C)C3CC3)cnn12.Cc1cc(N2CCOCC2)nc2c(C(=O)NC(C)C3CC3)cnn12
InChIInChI=1S/2C19H21N5O.C18H23F2N5O.C18H25N5O2.C17H23N5O2/c1-3-14-10-17(16-6-4-5-9-20-16)23-18-15(11-21-24(14)18)19(25)22-12(2)13-7-8-13;1-3-14-10-17(16-6-4-5-9-20-16)24-18(23-14)15(11-21-24)19(25)22-12(2)13-7-8-13;1-11-8-15(24-7-3-6-18(19,20)10-24)23-16-14(9-21-25(11)16)17(26)22-12(2)13-4-5-13;1-12-10-15(22-6-8-25-9-7-22)20-16-14(11-19-23(12)16)17(24)21-18(2,3)13-4-5-13;1-11-9-15(21-5-7-24-8-6-21)20-16-14(10-18-22(11)16)17(23)19-12(2)13-3-4-13/h2*4-6,9-13H,3,7-8H2,1-2H3,(H,22,25);8-9,12-13H,3-7,10H2,1-2H3,(H,22,26);10-11,13H,4-9H2,1-3H3,(H,21,24);9-10,12-13H,3-8H2,1-2H3,(H,19,23)
InChIKeyCVPWQYJJFIMKMT-UHFFFAOYSA-N
MW1707.07 g/mol
LogP11.76
Rot. Bonds22
About N-(1-cyclopropylethyl)-5-(3,3-difluoropiperidin-1-yl)-7-methylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-5-ethyl-7-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-ethyl-5-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(2-cyclopropylpropan-2-yl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide
N-(1-cyclopropylethyl)-5-(3,3-difluoropiperidin-1-yl)-7-methylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-5-ethyl-7-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-ethyl-5-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(2-cyclopropylpropan-2-yl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide (PubChem CID 163502094) has the molecular formula C91H113F2N25O7 and a molecular weight of 1707.07 g/mol. Its IUPAC name is N-(1-cyclopropylethyl)-5-(3,3-difluoropiperidin-1-yl)-7-methylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-5-ethyl-7-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-ethyl-5-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(2-cyclopropylpropan-2-yl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide.
Molecular Properties
| Compound Name | N-(1-cyclopropylethyl)-5-(3,3-difluoropiperidin-1-yl)-7-methylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-5-ethyl-7-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-ethyl-5-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(2-cyclopropylpropan-2-yl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide |
|---|---|
| PubChem CID | 163502094 |
| Molecular Formula | C91H113F2N25O7 |
| Molecular Weight | 1707.07 g/mol |
| Exact Mass | 1705.92 |
| IUPAC Name | N-(1-cyclopropylethyl)-5-(3,3-difluoropiperidin-1-yl)-7-methylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-5-ethyl-7-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-ethyl-5-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(2-cyclopropylpropan-2-yl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide |
| SMILES | CCc1cc(-c2ccccn2)n2ncc(C(=O)NC(C)C3CC3)c2n1.CCc1cc(-c2ccccn2)nc2c(C(=O)NC(C)C3CC3)cnn12.Cc1cc(N2CCCC(F)(F)C2)nc2c(C(=O)NC(C)C3CC3)cnn12.Cc1cc(N2CCOCC2)nc2c(C(=O)NC(C)(C)C3CC3)cnn12.Cc1cc(N2CCOCC2)nc2c(C(=O)NC(C)C3CC3)cnn12 |
| InChI | InChI=1S/2C19H21N5O.C18H23F2N5O.C18H25N5O2.C17H23N5O2/c1-3-14-10-17(16-6-4-5-9-20-16)23-18-15(11-21-24(14)18)19(25)22-12(2)13-7-8-13;1-3-14-10-17(16-6-4-5-9-20-16)24-18(23-14)15(11-21-24)19(25)22-12(2)13-7-8-13;1-11-8-15(24-7-3-6-18(19,20)10-24)23-16-14(9-21-25(11)16)17(26)22-12(2)13-4-5-13;1-12-10-15(22-6-8-25-9-7-22)20-16-14(11-19-23(12)16)17(24)21-18(2,3)13-4-5-13;1-11-9-15(21-5-7-24-8-6-21)20-16-14(10-18-22(11)16)17(23)19-12(2)13-3-4-13/h2*4-6,9-13H,3,7-8H2,1-2H3,(H,22,25);8-9,12-13H,3-7,10H2,1-2H3,(H,22,26);10-11,13H,4-9H2,1-3H3,(H,21,24);9-10,12-13H,3-8H2,1-2H3,(H,19,23) |
| InChIKey | CVPWQYJJFIMKMT-UHFFFAOYSA-N |
| XLogP | 11.76 |
| TPSA | 350.41 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 27 |
| Rotatable Bonds | 22 |
| Heavy Atoms | 125 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1707.07 |
| LogP ≤ 5 | 11.76 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 27 |
Frequently Asked Questions
What is the IUPAC name of N-(1-cyclopropylethyl)-5-(3,3-difluoropiperidin-1-yl)-7-methylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-5-ethyl-7-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-ethyl-5-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(2-cyclopropylpropan-2-yl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide?
The IUPAC name of N-(1-cyclopropylethyl)-5-(3,3-difluoropiperidin-1-yl)-7-methylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-5-ethyl-7-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-ethyl-5-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(2-cyclopropylpropan-2-yl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide (CID 163502094) is N-(1-cyclopropylethyl)-5-(3,3-difluoropiperidin-1-yl)-7-methylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-5-ethyl-7-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-ethyl-5-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(2-cyclopropylpropan-2-yl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide.
What is the SMILES notation for N-(1-cyclopropylethyl)-5-(3,3-difluoropiperidin-1-yl)-7-methylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-5-ethyl-7-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-ethyl-5-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(2-cyclopropylpropan-2-yl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide?
The canonical SMILES for N-(1-cyclopropylethyl)-5-(3,3-difluoropiperidin-1-yl)-7-methylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-5-ethyl-7-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-ethyl-5-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(2-cyclopropylpropan-2-yl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide is CCc1cc(-c2ccccn2)n2ncc(C(=O)NC(C)C3CC3)c2n1.CCc1cc(-c2ccccn2)nc2c(C(=O)NC(C)C3CC3)cnn12.Cc1cc(N2CCCC(F)(F)C2)nc2c(C(=O)NC(C)C3CC3)cnn12.Cc1cc(N2CCOCC2)nc2c(C(=O)NC(C)(C)C3CC3)cnn12.Cc1cc(N2CCOCC2)nc2c(C(=O)NC(C)C3CC3)cnn12.
What is the InChIKey of N-(1-cyclopropylethyl)-5-(3,3-difluoropiperidin-1-yl)-7-methylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-5-ethyl-7-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-ethyl-5-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(2-cyclopropylpropan-2-yl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide?
The InChIKey is CVPWQYJJFIMKMT-UHFFFAOYSA-N. The full InChI is InChI=1S/2C19H21N5O.C18H23F2N5O.C18H25N5O2.C17H23N5O2/c1-3-14-10-17(16-6-4-5-9-20-16)23-18-15(11-21-24(14)18)19(25)22-12(2)13-7-8-13;1-3-14-10-17(16-6-4-5-9-20-16)24-18(23-14)15(11-21-24)19(25)22-12(2)13-7-8-13;1-11-8-15(24-7-3-6-18(19,20)10-24)23-16-14(9-21-25(11)16)17(26)22-12(2)13-4-5-13;1-12-10-15(22-6-8-25-9-7-22)20-16-14(11-19-23(12)16)17(24)21-18(2,3)13-4-5-13;1-11-9-15(21-5-7-24-8-6-21)20-16-14(10-18-22(11)16)17(23)19-12(2)13-3-4-13/h2*4-6,9-13H,3,7-8H2,1-2H3,(H,22,25);8-9,12-13H,3-7,10H2,1-2H3,(H,22,26);10-11,13H,4-9H2,1-3H3,(H,21,24);9-10,12-13H,3-8H2,1-2H3,(H,19,23).
What are the key properties of N-(1-cyclopropylethyl)-5-(3,3-difluoropiperidin-1-yl)-7-methylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-5-ethyl-7-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-ethyl-5-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(2-cyclopropylpropan-2-yl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide?
N-(1-cyclopropylethyl)-5-(3,3-difluoropiperidin-1-yl)-7-methylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-5-ethyl-7-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-ethyl-5-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(2-cyclopropylpropan-2-yl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide has a molecular weight of 1707.07 g/mol, XLogP of 11.76, 22 rotatable bonds, 5 hydrogen bond donors, and 27 hydrogen bond acceptors.
Where does this data come from?
All data for N-(1-cyclopropylethyl)-5-(3,3-difluoropiperidin-1-yl)-7-methylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-5-ethyl-7-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-ethyl-5-pyridin-2-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(1-cyclopropylethyl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide;N-(2-cyclopropylpropan-2-yl)-7-methyl-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide is sourced from PubChem (CID 163502094), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 163502094 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.